Powered by

Stock Monthly: Antibe Therapeutics continues significant uptrend; soars 15% Monday September 30, 2019 17:00 EDT

Sep 30, 2019 - News Bites Canadian Markets
Board and Executive Moves-Financial Results


Antibe Therapeutics (TSXV:ATE), Canada's 17th largest Biotechnology company by market cap, rose for a second month on Monday bringing its a two-month rise to 11.0c or 39.3%. The share price soared 5.0c (or 14.7%) in the past month to close at 39.0c on Monday September 30. The volume was 0.8 times average trading per month of 12.8 million shares. Compared with the S&P/TSX 60 Index which rose 17.9 points (or 1.8%) in the month, this represented a relative price ...